Chemotherapy of ATL

Gann Monographs on Cancer Research

Volumn 50, Issue , 2003, Pages 263-276

  Tobinai, Kensei ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE INHIBITOR; ALPHA INTERFERON; ANTIBODY CONJUGATE; ANTINEOPLASTIC AGENT; BASILIXIMAB; BLEOMYCIN; CARBOPLATIN; CLADRIBINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P INHIBITOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR ANTIBODY; IRINOTECAN; METHOTREXATE; MONOCLONAL ANTIBODY; NIMUSTINE; PENTOSTATIN; PREDNISOLONE; PROCARBAZINE; RADIOIMMUNOCONJUGATE; SOBUZOXANE; TAX PROTEIN; UNCLASSIFIED DRUG; VINCRISTINE; VINDESINE; YTTRIUM 90; ZIDOVUDINE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG EFFICACY; DRUG RESPONSE; GENERAL CONDITION IMPROVEMENT; HUMAN; INFECTION; ISOTOPE LABELING; LEUKOPENIA; LIVER TOXICITY; MULTIDRUG RESISTANCE; NAUSEA; NEUTROPENIA; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; OUTCOMES RESEARCH; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; SURVIVAL RATE; T CELL LEUKEMIA; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

EID: 24644483193     PISSN: 00720151     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (31)

1. Gill, P. S., Harrington, W., Kaplan, M. H., Ribeiro, R. C., Bennett, J. M., Liebman, H. A., Bernstein-Singer, M., Espina, B. M., Cabral, L., and Allen, S. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N. Engl. J. Med., 332, 1744-1748 (1995).
2. Hermine, O., Blouscary, D., Gessain, A., Turlure, P., Leblond, V., Franck, N., Buzyn-Veil, A., Rio, B., Macintyre, E., and Dreyfus, F. Treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N. Engl. J. Med., 332, 1749-1751 (1995).
3. Kuwazuru, Y., Hanada, S., Furukawa, T., Yoshimura, A., Sumizawa, T., Utsunomiya, A., Ishibashi, K., Saito, T., Uozumi, K., and Maruyama, M. Expression of p-glycoprotein in adult T-cell leukemia cells. Blood, 76, 2065-2071 (1990).
4. Lau, A., Nightingale, S., Taylor, G. P., Gant, T. W., and Cann, A. J. Enhanced MDR1 gene expression in human T-cell leukemia virus-I-infected patients offers new prospects for therapy. Blood, 91, 2467-2474 (1998).
5. Lymphoma Study Group. Final results of cooperative study of VEPA [vincristine, cyclophosphamide (Endoxan), prednisolone and adriamycin] therapy in advanced adult non-Hodgkin's lymphoma: relation between T- or B-cell phenotype and response. Jpn. J. Clin. Oncol., 12, 227-238 (1982).
6. Lymphoma Study Group. Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Leuk. Res., 15, 81-90 (1991).
7. Ohno, R., Masaoka, T., Shirakawa, S., Sakamoto, S., Hirano, M., Hanada, S., Yasunaga, K., Yokomaku, S., Mitomo, Y., and Nagai, K. Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine). Cancer, 71, 2217-2221 (1993).
8. Ohno, R., Okada, K., Masaoka, T., Kuramoto, A., Arima, T., Yoshida, Y., Ariyoshi, H., Ichimaru, M., Sakai, Y., and Oguro, M. An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma. J. Clin. Oncol., 8, 1907-1912 (1990).
9. Ohtsu, T., Sasaki, Y., Igarashi, T., Murayama, T., Kobayashi, Y., and Tobinai, K. Unexpected hepatotoxicities in patients with non-Hodgkin's lymphoma treated with irinotecan (CPT-11) and etoposide. Jpn. J. Clin. Oncol., 28, 502-506 (1998).
10. Shimoyama, M. Chemotherapy of ATL. In "Adult T-cell Leukaemia," ed. K. Takatsuki, pp. 221-237 (1994). Oxford University Press, Oxford.
11. Shimoyama, M. and members of the Lymphoma Study Group (1984-1987). Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. Br. J. Haematol., 79, 428-437 (1991).
12. Shimoyama, M., Ota, K., Kikuchi, M., Yunoki, K., Konda, S., Takatsuki, K., Ichimaru, M., Ogawa, M., Kimura, I., Tominaga, S., Tsugane, S., Taguchi, H., Minato, K., Takenaka, T., Tobinai, K., Kurita, S., Oyama, A., Hisano, S., Kozuru, M., Matsumoto, M., Nomura, K., Takiguchi, T., Sugai, S., Yamaguchi, K., Hattori, T., Kinoshita, K., Tajima, K., Suemasu, K. for the Lymphoma Study Group. Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M. J. Clin. Oncol., 6, 128-141 (1988).
13. Shimoyama, M., Ota, K., Kikuchi, M., Yunoki, K., Konda, S., Takatsuki, K., Ichimaru, M., Tominaga, S., Tsugane, S., Minato, K., Tobinai, K., Oyama, A., Hisano, S., Matsu-moto, M., Takiguchi, T., Yamaguchi, K., Kinoshita, K., Tajima, K., Suemasu, K. for the Lymphoma Study Group (1981-1983). Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. J. Clin. Oncol., 6, 1088-1097 (1988).
14. Shimoyama, M., Oyama, A., Tajima, K., Tobinai, K., Minato, K., Takenaka, T., Konda, C., Takeyama, K., Kohno, A., and Narabayashi, M. Differences in clinicopathological characteristics and major prognostic factors between B-lymphoma and peripheral T-lymphoma excluding adult T-cell leukemia/lymphoma. Leuk. Lymphoma, 10, 335-342 (1993).
15. Takatsuki, K., Uchiyama, T., Sagawa, K., and Yodoi, J. Adult T cell leukemia in Japan. In "Topics in Hematology," ed. S. Seno, F. Takaku, and S. Irino, pp. 73-77 (1977). Excerpta Medica, Amsterdam.
16. Teshima, T., Akashi, K., Shibuya, T., Taniguchi, S., Okamura, T., Harada, M., Sumida, I., Hanada, M., and Niho, Y. Central nervous system involvement in adult T-cell leukemia/lymphoma. Cancer, 65, 327-332 (1990).
17. Tobinai, K., Hotta, T., Saito, H., Ohnishi, K., Ohno, R., Ogura, M., Ariyoshi, Y., Takeyama, K., Kobayashi, T., Ohashi, Y., and Shirakawa, S. Combination phase I/II study of irinotecan hydrochloride and carboplatin in relapsed or refractory non-Hodgkin's lymphoma. Jpn. J. Clin. Oncol., 26, 455-460 (1996).
18. Tobinai, K., Kobayashi, Y., Shimoyama, M. (letter), Gill, P. S., Harrington, W., and Levine, A. M. (the authors' reply). Interferon alfa and zidovudine in adult T-cell leukemia-lymphoma (Correspondence). N. Engl. J. Med., 333, 1285-1286 (1995).
19. Tobinai, K., Ogura, M., Hotta, T., Kobayashi, Y., Narabayashi, M., Suzuki, R., Kinoshita, T., Kozuru, M., Uike, N., and Ohashi, Y. Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Jpn. J. Clin. Oncol., 27, 146-153 (1997).
20. Tobinai, K., Shimoyama, M., Inoue, S., Takayasu, S., Mikuni, C., Kozuru, M., Oda, S., and Nakajima, H. Phase I study of YK-176 (2′-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. Jpn. J. Clin. Oncol., 22, 164-171 (1992).
21. Tobinai, K., Shimoyama, M., Minato, K., Shirakawa, S., Hotta, T., Fukuhara, S., Suzuki, H., Ichimaru, M., Sai, T., Konda, S., Mikuni, C., Toki, H., Kozuru, M., Deura, K., Takatsuki, K. for the Lymphoma Study Group, JCOG (1987-91). Japan Clinical Oncology Group phase II trial of second-generation "LSG4 protocol" in aggressive T- and B-lymphoma: a new predictive model for T- and B-lymphoma (Abstract). Proc. Am. Soc. Clin. Oncol., 13, 378 (1994).
22. Tobinai, K., Shimoyama, M., Tajima, K., Kozuru, M., Tomonaga, M., Araki, K., Kasai, M., Takatsuki, K., Tara, M., Hotta, T., Mikuni, C., members of the 30 institutions for the JCOG-Lymphoma Study Group. Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group (JCOG) Study #9109 (Abstract). Proc. Am. Soc. Clin. Oncol., 14, 390 (1995).
23. Tobinai, K., Uike, N., Saburi, Y., Ohashi, Y. and members for the Cladribine/ATL Study Group. Phase II study of cladribine in adult T-cell leukemia-lymphoma. Proc. Am. Soc. Clin. Oncol., 19, Abstr. #149 (2000).
24. Tsuda, H., Takatsuki, K., Ohno, R., Masaoka, T., Okada, K., Shirakawa, S., Ohashi, Y., and Ota, K. Treatment of adult T-cell leukemia-lymphoma with irinotecan hydrochloride. Br. J. Cancer, 70, 771-774 (1994).
25. Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., and Uchino, H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood, 50, 481-492 (1977).
26. Utsunomiya, A., Hanada, S., Terada, A., Kodama, M., Uematsu, T., Tsukasa, S., Hashimoto, S., and Tokunaga, M. Adult T-cell leukemia with leukemia cell infiltration into the gastrointestinal tract. Cancer, 61, 824-828 (1988).
27. Waldmann, T. A. Multichain interleukin-2 receptor: a target for immunotherapy in lymphoma. J. Natl. Cancer Int., 81, 914-923 (1989).
28. Waldmann, T. A., White, J. D., Carrasquillo, J. A., Reynolds, J. C., Paik, C. H., Gansow, O. A., Brechbiel, M. W., Jaffe, E. S., Fleisher, T. A., and Goldman, C. K. Radioimmunotherapy of interleukin-2Ra-expressing adult T-cell leukemia with yttrium-90-labeled anti-Tac. Blood, 86, 4063-4075 (1995).
29. Yamada, Y., Kamihira, S., Murata, K., Yamamura, M., Maeda, T., Tsukasaki, K., Jubash, T., Atogami, S., Sohda, H., Taguchi, T., and Tomonaga, M. Frequent hepatic involvement in adult T-cell leukemia: comparison with non-Hodgkin's lymphoma. Leuk. Lymphoma, 26, 327-335 (1997).
30. Yamada, Y., Tomonaga, M., Fukuda, H., Hanada, S., Utsunomiya, A., Tara, M., Sano, M., Ikeda, S., Takatsuki, K., Kozuru, M., Araki, K., Kawano, F., Niimi, M., Tobinai, K., Hotta, T., Shimoyama, M. and members of the JCOG-Lymphoma Study Group (LSG) (1994-1996). A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukemia-lymphoma (ATL): Japan Clinical Oncology Group (JCOG) Study 9303. Br. J. Haematol., 113, 375-382 (2001).
31. Yoshioka, R., Yamaguchi, K., Yoshinaga, T., and Takatsuki, K. Pulmonary complications in patients with adult T-cell leukemia. Cancer, 55, 2491-2494 (1985).